Characterization of Cubosomes As a Targeted and Sustained Transdermal Delivery System for Capsaicin

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2015 Sep 9

PMID 26345516

Citations 26

Authors

Xinsheng Peng

Yanfang Zhou

Ke Han

Lingzhen Qin

Linghui Dian

Ge Li

Xin Pan

Chuanbin Wu

Affiliations

Soon will be listed here.

Abstract

Phytantriol- and glycerol monooleate-based cubosomes were produced and characterized as a targeted and sustained transdermal delivery system for capsaicin. The cubosomes were prepared by emulsification and homogenization of phytantriol (F1), glycerol monooleate (F2), and poloxamer dispersions, characterized for morphology and particle size distribution by transmission electron microscope and photon correlation spectroscopy. Their Im3m crystallographic space group was confirmed by small-angle X-ray scattering. An in vitro release study showed that the cubosomes provided a sustained release system for capsaicin. An in vitro diffusion study conducted using Franz diffusion cells indicated that the skin retention of capsaicin from cubosomes in the stratum corneum was much higher (2.75±0.22 μg versus 4.32±0.13 μg, respectively) than that of capsaicin cream (0.72±0.13 μg). The stress testing showed that the cubosome formulations were stable under strong light and high temperature for up to 10 days. After multiapplications on mouse skin, the irritation of capsaicin cubosomes and cream was light with the least amount of side effects. Overall, the present study demonstrated that cubosomes may be a suitable skin-targeted and sustained delivery system for the transdermal administration of capsaicin.

Citing Articles

Development and Characterization of Sulfasalazine Cubosomes for Potential Transdermal Drug Delivery.

Mathew M, Patil A, G H Pharm Nanotechnol. 2024; 13(2):320-327.

PMID: 38362692 PMC: 11851143. DOI: 10.2174/0122117385269522231113041029.

Subconjunctival Delivery of Sorafenib-Tosylate-Loaded Cubosomes for Facilitated Diabetic Retinopathy Treatment: Formulation Development, Evaluation, Pharmacokinetic and Pharmacodynamic (PKPD) Studies.

Madhusudhan S, Gupta N, Rahamathulla M, Chidambaram S, Osmani R, Ghazwani M Pharmaceutics. 2023; 15(10).

PMID: 37896180 PMC: 10610393. DOI: 10.3390/pharmaceutics15102419.

A short review on the applicability and use of cubosomes as nanocarriers.

Palma A, Casadei B, Lotierzo M, de Castro R, Barbosa L Biophys Rev. 2023; 15(4):553-567.

PMID: 37681099 PMC: 10480096. DOI: 10.1007/s12551-023-01089-y.

Recent Progress in Gels for Neuropathic Pain.

Puscasu C, Zanfirescu A, Negres S Gels. 2023; 9(5).

PMID: 37233008 PMC: 10217869. DOI: 10.3390/gels9050417.

Cubosomes in Drug Delivery-A Comprehensive Review on Its Structural Components, Preparation Techniques and Therapeutic Applications.

Sivadasan D, Sultan M, Alqahtani S, Javed S Biomedicines. 2023; 11(4).

PMID: 37189732 PMC: 10135881. DOI: 10.3390/biomedicines11041114.

References

Peng X, Yang Z, Chen M, Han K, Xiao Y, Wu C . [Preparation, characterization and content determination of cubic phase gel containing capsaicin]. Zhongguo Zhong Yao Za Zhi. 2011; 35(23):3123-6. View

Wadsten-Hindrichsen P, Bender J, Unga J, Engstrom S . Aqueous self-assembly of phytantriol in ternary systems: effect of monoolein, distearoylphosphatidylglycerol and three water-miscible solvents. J Colloid Interface Sci. 2007; 315(2):701-13. DOI: 10.1016/j.jcis.2007.07.011. View

Peng X, Zhou Y, Han K, Qin L, Wu C . [Preparation and in vitro study on diffusion of capsaicin cubosome]. Zhongguo Zhong Yao Za Zhi. 2014; 39(4):644-7. View

Salentinig S, Yaghmur A, Guillot S, Glatter O . Preparation of highly concentrated nanostructured dispersions of controlled size. J Colloid Interface Sci. 2008; 326(1):211-20. DOI: 10.1016/j.jcis.2008.07.021. View

Mitragotri S, Burke P, Langer R . Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov. 2014; 13(9):655-72. PMC: 4455970. DOI: 10.1038/nrd4363. View

Wohlrab J, Neubert R, Heskamp M, Michael J . Cutaneous drug delivery of capsaicin after in vitro administration of the 8% capsaicin dermal patch system. Skin Pharmacol Physiol. 2014; 28(2):65-74. DOI: 10.1159/000362740. View

Lee K, Nguyen T, Hanley T, Boyd B . Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. Int J Pharm. 2008; 365(1-2):190-9. DOI: 10.1016/j.ijpharm.2008.08.022. View

Somagoni J, Boakye C, Godugu C, Patel A, Faria H, Zucolotto V . Nanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluation. PLoS One. 2014; 9(12):e115952. PMC: 4278799. DOI: 10.1371/journal.pone.0115952. View

Rollyson W, Stover C, Brown K, Perry H, Stevenson C, McNees C . Bioavailability of capsaicin and its implications for drug delivery. J Control Release. 2014; 196:96-105. PMC: 4267963. DOI: 10.1016/j.jconrel.2014.09.027. View

10.

Morsi N, Abdelbary G, Ahmed M . Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur J Pharm Biopharm. 2013; 86(2):178-89. DOI: 10.1016/j.ejpb.2013.04.018. View

11.

Rottke M, Lunter D, Daniels R . In vitro studies on release and skin permeation of nonivamide from novel oil-in-oil-emulsions. Eur J Pharm Biopharm. 2013; 86(2):260-6. DOI: 10.1016/j.ejpb.2013.09.018. View

12.

Pan X, Han K, Peng X, Yang Z, Qin L, Zhu C . Nanostructured cubosomes as advanced drug delivery system. Curr Pharm Des. 2013; 19(35):6290-7. DOI: 10.2174/1381612811319350006. View

13.

Steluti R, de Rosa F, Collett J, Tedesco A, Bentley M . Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. Eur J Pharm Biopharm. 2005; 60(3):439-44. DOI: 10.1016/j.ejpb.2005.01.011. View

14.

Caffrey M . A lipid's eye view of membrane protein crystallization in mesophases. Curr Opin Struct Biol. 2000; 10(4):486-97. DOI: 10.1016/s0959-440x(00)00119-6. View

15.

Zhang P, Gao W, Zhang L, Chen L, Shen Q, Wang X . In vitro evaluation of topical microemulsion of capsaicin free of surfactant. Biol Pharm Bull. 2008; 31(12):2316-20. DOI: 10.1248/bpb.31.2316. View

16.

Gupta R, Gupta M, Mangal S, Agrawal U, Vyas S . Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy. Artif Cells Nanomed Biotechnol. 2014; 44(3):825-34. DOI: 10.3109/21691401.2014.984301. View

17.

Peng X, Wen X, Pan X, Wang R, Chen B, Wu C . Design and in vitro evaluation of capsaicin transdermal controlled release cubic phase gels. AAPS PharmSciTech. 2010; 11(3):1405-10. PMC: 2974133. DOI: 10.1208/s12249-010-9481-1. View

18.

Huang X, Xue J, Jiang A, Zhu H . Capsaicin and its analogues: structure-activity relationship study. Curr Med Chem. 2013; 20(21):2661-72. DOI: 10.2174/0929867311320210004. View

19.

Bender J, Ericson M, Merclin N, Iani V, Rosen A, Engstrom S . Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J Control Release. 2005; 106(3):350-60. DOI: 10.1016/j.jconrel.2005.05.010. View

20.

Sharma S, Vij A, Sharma M . Mechanisms and clinical uses of capsaicin. Eur J Pharmacol. 2013; 720(1-3):55-62. DOI: 10.1016/j.ejphar.2013.10.053. View